Boomerang Medical announced today that it raised $20 million in a Series B financing to support its implantable ...

The OMass partnership will boost Roche’s strategy in inflammatory bowel diseases, currently led by afimkibart, an anti-TL1A ...

OMass Therapeutics partners with Genentech to advance innovative treatments for inflammatory bowel disease, leveraging their ...

Collaboration leverages OMass’ OdyssionTM platform for the continued development of oral small molecules against a first-in-class target in ...

Certain diets can help improve inflammatory bowel disease (IBD) symptoms and support gut health—particularly those rich in ...

Medically reviewed by Kumkum S. Patel, MD Inflammatory bowel disease (IBD) is a group of conditions that cause inflammation in the digestive system. The two most common forms are ulcerative ...

India faces a rising tide of inflammatory bowel disease (IBD), fueled by urban lifestyles and dietary shifts. Conditions like ...

Up to 3.1 million people live with inflammatory bowel disease (IBD), which includes gastrointestinal disorders such as ulcerative colitis (UC) and Crohn’s disease that cause inflammation in the ...

Patients with both axial spondyloarthritis and inflammatory bowel disease have distinct features, yet the latter's presence ...

Inflammatory bowel disease (IBD) is the collective term for ulcerative colitis (UC) and Crohn’s disease (CD), two separate conditions that cause chronic inflammation in the gastrointestinal (GI ...